TSP-50 targeting monoclonal antibodies (Alethia)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTSP-50 targeting monoclonal antibodies (Alethia)
Drug Alias NameAB-0440-targeting monoclonal antibodies (Alethia)anti-testes specific protease 50 antibody (Alethia)AB-0440a
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsBone ResorptionOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlethia Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlethia Biotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsBone ResorptionOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A